Name | Description | Industry | Official Website | Location | ||
---|---|---|---|---|---|---|
Autolus is a biopharmaceutical company focused on programmed T-cell therapies for treatment of cancer. Autolus was founded in 2014 and is based in London, UK. Autolus Limited is a subsidiary of Autolus Holdings (UK) Limited. | ||||||
Cellectis is a biopharmaceutical company developing cancer immunotherapies. | ||||||
Carisma Therapeutics is a biotechnology company founded in 2016 to bring the potheyr of adoptive cellular immunotherapy to solid tumor patients through a novel platform using chimeric antigen receptor macrophages (CARMA). | ||||||
SparingVision is a retinal Gene Therapy Treatments founded by Jose alain sahel. | ||||||
Araris Biotech is a fast/precise production of antibody-drug conjugates founded in 2019 by Philipp Spycher. | ||||||
Code Biotherapeutics is a DNA-based Gene Therapy Vector founded in 2020 by Brian J. McVeigh, Lori Getts and Robert Getts. | ||||||
March Biosciences is a clinical-stage cell therapy company that develops CAR-T cell strategies to address hematological cancers. | ||||||
Provider of targeted radioligand therapy platform for cancer treatment. | ||||||
ViaNautis is a drug delivery platform founded in 2018. |